Thursday, October 27, 2011

European Medicines Agency - News and Events - Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy

European Medicines Agency - News and Events - Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy: "Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy

PROWESS-SHOCK study shows no gain in 28-day survival of septic shock patients"

'via Blog this'

No comments:

Post a Comment